Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Cyclodextrin-enabled δ-Tocotrienol for Treating Stress and Memory Dysfunction: Molecular Insights, Biotechnological Applications and Biomanufacturing Implications. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1155/2017/8416763
10.1155/2017/8416763 · External reference
10.3390/ijms20184472
10.3390/ijms20184472 · External reference
10.3389/fnagi.2024.1389454
10.3389/fnagi.2024.1389454 · External reference
10.1016/j.redox.2018.01.008
10.1016/j.redox.2018.01.008 · External reference
10.1002/1873-3468.12964
10.1002/1873-3468.12964 · External reference
10.3390/antiox10121917
10.3390/antiox10121917 · External reference
10.1016/j.mad.2023.111855
10.1016/j.mad.2023.111855 · External reference
10.1152/physrev.00030.2022
10.1152/physrev.00030.2022 · External reference
10.3389/fnmol.2020.00041
10.3389/fnmol.2020.00041 · External reference
10.1016/j.bmc.2025.118241
10.1016/j.bmc.2025.118241 · External reference
10.3389/fnagi.2022.944697
10.3389/fnagi.2022.944697 · External reference
10.3233/jad-170732
10.3233/jad-170732 · External reference
10.1016/j.neures.2011.05.008
10.1016/j.neures.2011.05.008 · External reference
10.1016/j.cell.2022.12.032
10.1016/j.cell.2022.12.032 · External reference
10.1016/j.actbio.2025.07.067
10.1016/j.actbio.2025.07.067 · External reference
10.1007/s00210-025-04235-3
10.1007/s00210-025-04235-3 · External reference
10.1002/jcp.30940
10.1002/jcp.30940 · External reference
10.3390/cells14070511
10.3390/cells14070511 · External reference
10.1016/j.neuropharm.2004.06.029
10.1016/j.neuropharm.2004.06.029 · External reference
10.1016/j.pbb.2009.05.009
10.1016/j.pbb.2009.05.009 · External reference
The neuroprotective effects of tocotrienol rich fraction and alpha tocopherol against glutamate injury in astrocytes
2014 · External reference
10.3390/ijms17111809
10.3390/ijms17111809 · External reference
10.3390/antiox14010115
10.3390/antiox14010115 · External reference
10.1158/0008-5472.can-15-2704
10.1158/0008-5472.can-15-2704 · External reference
10.1016/j.jff.2024.106178
10.1016/j.jff.2024.106178 · External reference
10.1007/s11745-007-3102-0
10.1007/s11745-007-3102-0 · External reference
10.1155/2013/101705
10.1155/2013/101705 · External reference
10.18632/oncotarget.15767
10.18632/oncotarget.15767 · External reference
10.1186/s12935-019-0876-0
10.1186/s12935-019-0876-0 · External reference
10.1159/000489128
10.1159/000489128 · External reference
10.3390/ijms262311682
10.3390/ijms262311682 · External reference
10.3390/ph16091274
10.3390/ph16091274 · External reference
10.3390/pharmaceutics17040506
10.3390/pharmaceutics17040506 · External reference
10.1016/j.jconrel.2020.09.043
10.1016/j.jconrel.2020.09.043 · External reference
10.3390/pharmaceutics17030288
10.3390/pharmaceutics17030288 · External reference
10.1021/acsabm.2c00233
10.1021/acsabm.2c00233 · External reference
10.3390/ijms22063255
10.3390/ijms22063255 · External reference
10.3390/ph18101592
10.3390/ph18101592 · External reference
10.1002/mabi.202400637
10.1002/mabi.202400637 · External reference
10.1021/acsami.2c09913
10.1021/acsami.2c09913 · External reference
10.1016/j.lwt.2018.10.067
10.1016/j.lwt.2018.10.067 · External reference
10.1084/jem.20121239
10.1084/jem.20121239 · External reference
Long-term administration of intravenous Trappsol® Cyclo™ (HP-β-CD) results in clinical benefits and stabilization or slowing of disease progression in patients with Niemann-Pick disease type C1: results of an international 48-week Phase I/II trial
2023 · External reference
10.1016/j.braindev.2024.03.002
10.1016/j.braindev.2024.03.002 · External reference
